Literature DB >> 8138589

Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2 alpha: additivity with the effect of norepinephrine, and synergism with epidermal growth factor.

M Refsnes1, G H Thoresen, O F Dajani, T Christoffersen.   

Abstract

Previous data obtained in vivo and in vitro suggest that both prostaglandins (PGs) and catecholamines may have a role in promoting hepatocyte proliferation, and PGE2 and PGF2 alpha have also been implicated as mediators of the mitogenic actions of epidermal growth factor (EGF) (and transforming growth factor alpha [TGF alpha]). We have studied the effects of PGs and norepinephrine on DNA synthesis in serum-free primary cultures of rat hepatocytes, and compared the PG effects with those of norepinephrine. PGE2, PGF2 alpha, PGD2, and the synthetic analog dimethyl-PGE2 markedly enhanced the DNA synthesis. A more quantitative analysis of the effects of PGE2 and PGF2 alpha on the DNA synthesis, in the presence and absence of EGF, indicated that these PGs interacted in an essentially multiplicative manner with the effect of EGF. The effects of PGE2 and PGF2 alpha showed almost complete additivity with the stimulation of DNA synthesis produced by maximally effective concentrations of norepinephrine. The data suggest a) that PGE2 and PGF2 alpha facilitate and synergize with, rather than mediate, the actions of EGF in hepatocytes, and b) that this effect of the PGs occurs by mechanisms that are at least partly distinct from those of norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138589     DOI: 10.1002/jcp.1041590106

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  Microsomal prostaglandin E synthase-1 protects against Fas-induced liver injury.

Authors:  Lu Yao; Weina Chen; Chang Han; Tong Wu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-21       Impact factor: 4.052

2.  Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.

Authors:  Guiying Li; Weina Chen; Chang Han; Tong Wu
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

3.  Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.

Authors:  Ingun Heiene Tveteraas; Monica Aasrum; Ingvild Johnsen Brusevold; John Ødegård; Thoralf Christoffersen; Dagny Sandnes
Journal:  Tumour Biol       Date:  2015-09-19

4.  p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines.

Authors:  Monica Aasrum; G Hege Thoresen; Thoralf Christoffersen; Ingvild J Brusevold
Journal:  J Cell Commun Signal       Date:  2018-01-29       Impact factor: 5.782

5.  Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.

Authors:  Guiying Li; Chang Han; Lihong Xu; Kyu Lim; Kumiko Isse; Tong Wu
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

6.  Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.

Authors:  Kristin M Müller; Ingun H Tveteraas; Monica Aasrum; John Ødegård; Mona Dawood; Olav Dajani; Thoralf Christoffersen; Dagny L Sandnes
Journal:  BMC Cancer       Date:  2011-10-02       Impact factor: 4.430

7.  Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.

Authors:  Ingun Heiene Tveteraas; Kristin Meisdalen Müller; Monica Aasrum; John Ødegård; Olav Dajani; Tormod Guren; Dagny Sandnes; Thoralf Christoffersen
Journal:  J Exp Clin Cancer Res       Date:  2012-09-11

8.  Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.

Authors:  Ewa Pomianowska; Dagny Sandnes; Krzysztof Grzyb; Aasa R Schjølberg; Monica Aasrum; Ingun H Tveteraas; Vegard Tjomsland; Thoralf Christoffersen; Ivar P Gladhaug
Journal:  BMC Cancer       Date:  2014-06-09       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.